{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-010378","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.901837+00:00","generated_at":"2026-06-17T07:55:50.013259+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PAVmed stockholders approve reverse stock split and authorized share reduction","bullets":["Approximately 70.8% of shares present or represented at March 31 special meeting.","Reverse split ratio range 1:5 to 1:15, board to decide timing and exact ratio by March 31, 2024.","Authorized shares reduced from 250M to 50M upon effectuation of reverse split.","Votes: 53,080,020 for, 15,037,559 against, 1,009,870 abstain, no broker non-votes.","Company reserved right to abandon the reverse split and authorized capital reduction."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-010378","json":"https://secwatch.observer/filing/0001493152-23-010378.json","markdown":"https://secwatch.observer/filing/0001493152-23-010378.md","text":"https://secwatch.observer/filing/0001493152-23-010378.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/0001493152-23-010378-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:55:50.013259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1348300735f8e8991c75c29d4048416fc2a53e4b","claim":"PAVmed Inc. shareholders approved A proposal to approve an amendment to the certificate of incorporation to effect a reverse stock split and an associated reduction in authorized shares at the 2023-03-31 meeting.","evidence_excerpt":"Stockholders representing approximately 70.8% of the shares outstanding and entitled to vote were present in person or by proxy. At the Special Meeting, the stockholders approved the sole proposal presented.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223010378/0001493152-23-010378-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-03-31"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}